Država: Združene države Amerike
Jezik: angleščina
Source: NLM (National Library of Medicine)
Potassium Citrate (UNII: EE90ONI6FF) (Anhydrous Citric Acid - UNII:XF417D3PSL), Citric Acid Monohydrate (UNII: 2968PHW8QP) (Anhydrous Citric Acid - UNII:XF417D3PSL)
Cypress Pharmaceutical, Inc.
Potassium Citrate
Potassium Citrate 3.3 g
ORAL
PRESCRIPTION DRUG
CYTRA-K CRYSTALS is an effective alkalinizing agent useful in those conditions where long-term maintenance of an alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract, especially when the administration of sodium salts is undesirable or contraindicated. In addition, it is a valuable adjuvant when administered with uricosuric agents in gout therapy, since urates tend to crystallize out of an acid urine. It is also effective in correcting the acidosis of certain renal tubular disorders where the administration of potassium citrate may be preferable. CYTRA-K CRYSTALS is highly concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. CYTRA-K CRYSTALS alkalinizes the urine without producing a systemic alkalosis in recommended dosage. It is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. Potassium cit
CYTRA-K CRYSTALS - 100 Packets/box (NDC 60258-005-01). Store at controlled room temperature, 15°-30°C (59°-86°F). Protect from excessive heat or freezing.
unapproved drug other
CYTRA-K CRYSTALS - POTASSIUM CITRATE AND CITRIC ACID GRANULE, FOR SOLUTION CYPRESS PHARMACEUTICAL, INC. _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- CYTRA-K CRYSTALS (POTASSIUM CITRATE AND CITRIC ACID FOR ORAL SOLUTION) RX ONLY NDC 60258-005-01 DESCRIPTION CYTRA-K CRYSTALS (potassium citrate and citric acid for oral solution) is a pleasant-tasting oral systemic alkalizer containing potassium citrate and citric acid in a sugar-free base. Each packet of CYTRA-K CRYSTALS, when reconstituted, provides the following amounts of active ingredients : Potassium Citrate Monohydrate 3300 mg Citric Acid Monohydrate 1002 mg and provides 30 mEq potassium, equivalent to 30 mEq bicarbonate (HCO ). INACTIVE INGREDIENTS Sodium saccharin, fruit punch flavor, and FD&C Red Dye #3. POTASSIUM CITRATE MONOHYDRATE has the chemical name: 1,2,3-Propanetricarboxylic acid, 2-hydroxy- ,tripotassium salt, monohydrate. Its chemical structure is as follows: C H K O · H O M.W. 324 .4 1 CITRIC ACID MONOHYDRATE has the chemical name: 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, monohydrate. Its chemical structure is as follows: 3 6 5 3 7 2 C H O · H O M.W. 210.14 CLINICAL PHARMACOLOGY Potassium citrate is absorbed and metabolized to potassium bicarbonate, thus acting as a systemic alkalizer. The effects are essentially those of chlorides before absorption and those of bicarbonates subsequently. Oxidation is virtually complete so that less than 5% of the potassium citrate is excreted in the urine unchanged. INDICATIONS AND USAGE CYTRA-K CRYSTALS is an effective alkalinizing agent useful in those conditions where long-term maintenance of an alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract, especially when the administration of sodium salts is undesirable or contraindicated. In addition, it is a valuable adjuvant when administered with uricosuri Preberite celoten dokument